PERSPECTA

News from every angle

← Back to headlines

Novavax sets 2026 revenue and 2028 opex targets

Novavax is targeting $230M-$270M in adjusted revenue for 2026 and refining its 2028 operational expenses to $150M-$200M.

6 May, 18:23 — 6 May, 18:23
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed1h ago

Novavax targets $230M-$270M 2026 adjusted revenue while refining 2028 opex to $150M-$200M

Read full article →

Related Stories

Flight with sick passenger from virus-hit ship is believed to have landed in Holland

12m ago

Borg Høiby Alleges Unfair Treatment

16m ago

Review Highlights Global Nurse Shortage in "Aftenvagt" Drama

21m ago

Hantavirus-Hit Cruise Ship Heads to Tenerife

23m ago